Huntington National Bank’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6 | Hold |
5,001
| – | – | ﹤0.01% | 3837 |
|
|
2025
Q1 | $4 | Hold |
5,001
| – | – | ﹤0.01% | 3920 |
|
|
2024
Q4 | $4 | Hold |
5,001
| – | – | ﹤0.01% | 3927 |
|
|
2024
Q3 | $20 | Hold |
5,001
| – | – | ﹤0.01% | 3488 |
|
|
2024
Q2 | $49 | Hold |
5,001
| – | – | ﹤0.01% | 2964 |
|
|
2024
Q1 | $40 | Hold |
5,001
| – | – | ﹤0.01% | 2920 |
|
|
2023
Q4 | $619 | Sell |
5,001
-10,000
| -67% | -$1.24K | ﹤0.01% | 2279 |
|
|
2023
Q3 | $1.41K | Sell |
15,001
-1,000
| -6% | -$94 | ﹤0.01% | 2149 |
|
|
2023
Q2 | $5.73K | Buy |
16,001
+2,000
| +14% | +$716 | ﹤0.01% | 1754 |
|
|
2023
Q1 | $5.04K | Buy |
14,001
+10,000
| +250% | +$3.6K | ﹤0.01% | 1723 |
|
|
2022
Q4 | $3.55K | Sell |
4,001
-2,000
| -33% | -$1.77K | ﹤0.01% | 1681 |
|
|
2022
Q3 | $9K | Hold |
6,001
| – | – | ﹤0.01% | 1583 |
|
|
2022
Q2 | $12K | Hold |
6,001
| – | – | ﹤0.01% | 1528 |
|
|
2022
Q1 | $14K | Hold |
6,001
| – | – | ﹤0.01% | 1490 |
|
|
2021
Q4 | $28K | Buy |
6,001
+1,000
| +20% | +$4.67K | ﹤0.01% | 1265 |
|
|
2021
Q3 | $38K | Hold |
5,001
| – | – | ﹤0.01% | 1058 |
|
|
2021
Q2 | $48K | Hold |
5,001
| – | – | ﹤0.01% | 970 |
|
|
2021
Q1 | $41K | Hold |
5,001
| – | – | ﹤0.01% | 906 |
|
|
2020
Q4 | $34K | Hold |
5,001
| – | – | ﹤0.01% | 933 |
|
|
2020
Q3 | $56K | Buy |
5,001
+3,000
| +150% | +$33.6K | ﹤0.01% | 758 |
|
|
2020
Q2 | $13K | Buy |
+2,001
| New | +$13K | ﹤0.01% | 1161 |
|